RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate

8th January 2025 Uncategorised 0

The FDA will require GSK and Pfizer to include on the label of their respiratory syncytial virus (RSV) vaccines a warning about the risk of developing Guillain-Barré syndrome (GBS), a rare neurological condition that can cause paralysis. The ruling will affect GSK’s Arexvy and Pfizer’s Abrysvo.

More: RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate
Source: fierce